The Rx Recap: June 8-14

Welcome to this week’s roundup of the most insightful and impactful articles from the sister publications of Dermatology Times, all under One MJH Life Sciences. Our network brings together expert perspectives, clinical advancements, and industry updates to keep clinicians informed and ahead of the curve. From cutting-edge treatments to practice management strategies, here’s a look at the top stories shaping the field of medicine.

Overweight, Obesity Associated With Neurologic and Neuropsychiatric Symptoms in Post-COVID-19 Condition

Débora Barbosa Ronca, PhD candidate and visiting scholar at Edith Cowan University, led a meta-analysis revealing that individuals who are overweight or obese are significantly more likely to experience long COVID neurological and neuropsychiatric symptoms, such as depression, memory issues, and sensory disturbances. Summarized by Pharmacy Times, the study evaluated over 139,000 adults across 18 studies from 23 countries, highlighting the global relevance of the findings. Ronca noted that excess fatty tissue may contribute to prolonged viral presence and inflammation, exacerbating post-COVID-19 condition.

Discouraged or Determined: How Politics Is Reshaping Public Health's Next Generation

College students pursuing careers in public health are grappling with uncertainty as US policy shifts threaten funding, global leadership, and job prospects in the field, according to an article in Infection Control Today. In interviews with 10 students across the country, reactions ranged from frustration and fear to renewed commitment, with many citing concerns about research cuts, weakened public trust, and future job insecurity. While some students are reconsidering their paths, others view these challenges as a call to action.

Cigna Launches AI Tools to Simplify Health Insurance, Improve Customer Experience

Cigna Healthcare has unveiled new digital tools within its myCigna portal to simplify health insurance tasks like checking benefits, estimating costs, and finding providers. This Managed Healthcare Executive article discusses how an AI-powered virtual assistant that offers personalized, conversational support for navigating coverage, billing, and care options. Additional features include smart claim submission, real-time cost tracking, and tailored provider matching. Early feedback shows strong user engagement and satisfaction.

Advancing Head and Neck Cancer Treatment: Insights From KEYNOTE-689

The KEYNOTE-689 trial evaluated the addition of pembrolizumab to standard treatment for resectable, locoregionally advanced head and neck squamous cell carcinoma (HNSCC). Targeted Oncology highlights results from the 714-patient global study showed a 27% reduction in the risk of recurrence or death, marking a significant improvement in event-free survival. The trial also highlighted the manageable safety profile of pembrolizumab, with immune-related adverse events primarily involving thyroid disorders. Researchers are awaiting overall survival data to further assess the regimen's long-term benefits.

Machine Learning and NMR Unite to Authenticate Wine with Near-Perfect Accuracy

Spectroscopy spotlights a recent study published in Beverages exploring a new method to improve wine authentication by combining machine learning algorithms with proton nuclear magnetic resonance (1H-NMR) spectroscopy. The study demonstrated that machine learning models, particularly logistic regression, achieved high accuracy in classifying wines by vintage, grape variety, and geographic origin. The innovation addresses concerns of wine fraud and mislabeling, offering a reliable, scalable solution for producers, regulatory agencies, and consumers, ensuring authenticity and boosting consumer confidence in wine purchases.

Want to read more on specialty care, pharmacy, industry sciences, and more? Check out MJH Life Sciences full list of brands here.